SAN FRANCISCO and MENLO PARK, Calif. — Invitae Corporation (NYSE: NVTA), a leading genetics company, and Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced a research collaboration focused on the investigation of clinically relevant molecular targets for use in the development of advanced diagnostic […]
SOUTH SAN FRANCISCO, Calif. — InterVenn, a San Francisco based biotechnology company innovating precision medicine and diagnostic products using next-generation mass spectrometry coupled to a proprietary artificial Intelligence/machine learning-based data processing engine, has announced a collaboration with Agilent Technologies, a leading provider of bio-analytical and scientific instrumentation. The signing of the collaboration took place on […]
Park Systems and Helmholtz Zentrum Berlin sign an agreement about a framework for joint research and development of metrology solutions for materials science We are particularly happy that with Park Systems we found a strong partner from industry who is known for their support of scientific research.” — Prof. Dr. Bernd Rech, Scientific Managing Director […]
Collaboration will utilize PacBio’s highly accurate HiFi sequencing to solve rare pediatric genetic diseases that have proven intractable in previous studies KANSAS CITY, Mo., and MENLO PARK, Calif. — Children’s Mercy Kansas City, one of the nation’s top pediatric medical systems, and Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of […]
ERS Genomics announces agreement with FASMAC to commercialize CRISPR/Cas9 research reagents in Japan
Food analysis and biotechnology company licenses gene editing technology Dublin, Ireland, and Kanagawa, Japan: ERS Genomics Limited (“ERS”), which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr. Emmanuelle Charpentier, today announced it has signed an agreement with FASMAC Co., Ltd (“FASMAC”) of Japan. Under the terms of the […]
ST. LOUIS & NATICK, Mass. — PierianDx, the leading clinical genomics informatics company, and Pillar Biosciences, a leading next-generation sequencing clinical oncology company, today announced a partnership that enables Pillar Biosciences to sell directly the PierianDx clinical genomic report in combination with its cancer profiling assays. Under the agreement, PierianDx will integrate the Pillar Biosciences […]
Partnership Combines Twist’s Leadership in DNA Synthesis and Synthetic Biology with Neogene’s Expertise in Personalized Engineered T Cell Therapies SOUTH SAN FRANCISCO, Calif. & AMSTERDAM & NEW YORK–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Neogene Therapeutics, Inc., a biotechnology […]
Partnership will develop and validate unique in vitro/in silico models for oral cavity products Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that, through a joint proposal with the St. Louis College of Pharmacy at University of Health Sciences and […]
CANTON, Mass. — Universal Sequencing Technology Corporation (‘UST’), a developer of Next Generation Sequencing (NGS) technologies, today is proud to announce a commercial relationship with Shanghai Bioscience Ltd. for the distribution of TELL-Seq WGS Library preparation kits in China. The TELL-Seq kit allows customers to transform their short-read DNA sequencer into a long-read DNA sequencer. The method […]
Virtual reality software which allows researchers to ‘walk’ inside and analyse individual cells could be used to understand fundamental problems in biology and develop new treatments for disease. Biology occurs in 3D, but up until now it has been difficult to interact with the data on a 2D computer screen in an intuitive and […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
